Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype

Corena V. Grant, Chase M. Carver, Shayne D. Hastings, Karthik Ramachandran, Madesh Muniswamy, April L Risinger, John A. Beutler, Susan L Mooberry

Research output: Contribution to journalArticle

Abstract

Purpose: Triple-negative breast cancers (TNBCs) represent a heterogeneous group of tumors. The lack of targeted therapies combined with the inherently aggressive nature of TNBCs results in a higher relapse rate and poorer overall survival. We evaluated the heterogeneity of TNBC cell lines for TRPC channel expression and sensitivity to cation-disrupting drugs. Methods: The TRPC1/4/5 agonist englerin A was used to identify a group of TNBC cell lines sensitive to TRPC1/4/5 activation and intracellular cation disruption. Quantitative RT-PCR, the sulforhodamine B assay, pharmacological inhibition, and siRNA-mediated knockdown approaches were employed. Epifluorescence imaging was performed to measure intracellular Ca2+ and Na+ levels. Mitochondrial membrane potential changes were monitored by confocal imaging. Results: BT-549 and Hs578T cells express high levels of TRPC4 and TRPC1/4, respectively, and are exquisitely, 2000- and 430-fold, more sensitive to englerin A than other TNBC cell lines. While englerin A caused a slow Na+ and nominal Ca2+ accumulation in Hs578T cells, it elicited rapid increases in cytosolic Ca2+ levels that triggered mitochondrial depolarization in BT-549 cells. Interestingly, BT-549 and Hs578T cells were also more sensitive to digoxin as compared to other TNBC cell lines. Collectively, these data reveal TRPC1/4 channels as potential biomarkers of TNBC cell lines with dysfunctional mechanisms of cation homeostasis and therefore sensitivity to cardiac glycosides. Conclusions: The sensitivity of BT-549 and Hs578T cells to englerin A and digoxin suggests a subset of TNBCs are highly susceptible to cation disruption and encourages investigation of TRPC1 and TRPC4 as potential new biomarkers of sensitivity to cardiac glycosides.

Original languageEnglish (US)
JournalBreast Cancer Research and Treatment
DOIs
StatePublished - Jan 1 2019

Fingerprint

Triple Negative Breast Neoplasms
Cell Line
Cations
Cardiac Glycosides
Digoxin
lissamine rhodamine B
Biomarkers
englerin A
Mitochondrial Membrane Potential
Small Interfering RNA
Homeostasis
Pharmacology
Recurrence
Polymerase Chain Reaction

Keywords

  • Cation disruption
  • Digoxin
  • Englerin A
  • Triple-negative breast cancer
  • TRPC1/4/5

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. / Grant, Corena V.; Carver, Chase M.; Hastings, Shayne D.; Ramachandran, Karthik; Muniswamy, Madesh; Risinger, April L; Beutler, John A.; Mooberry, Susan L.

In: Breast Cancer Research and Treatment, 01.01.2019.

Research output: Contribution to journalArticle

Grant, Corena V. ; Carver, Chase M. ; Hastings, Shayne D. ; Ramachandran, Karthik ; Muniswamy, Madesh ; Risinger, April L ; Beutler, John A. ; Mooberry, Susan L. / Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. In: Breast Cancer Research and Treatment. 2019.
@article{712a42ae77e741d99caffc71a58ceaf4,
title = "Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype",
abstract = "Purpose: Triple-negative breast cancers (TNBCs) represent a heterogeneous group of tumors. The lack of targeted therapies combined with the inherently aggressive nature of TNBCs results in a higher relapse rate and poorer overall survival. We evaluated the heterogeneity of TNBC cell lines for TRPC channel expression and sensitivity to cation-disrupting drugs. Methods: The TRPC1/4/5 agonist englerin A was used to identify a group of TNBC cell lines sensitive to TRPC1/4/5 activation and intracellular cation disruption. Quantitative RT-PCR, the sulforhodamine B assay, pharmacological inhibition, and siRNA-mediated knockdown approaches were employed. Epifluorescence imaging was performed to measure intracellular Ca2+ and Na+ levels. Mitochondrial membrane potential changes were monitored by confocal imaging. Results: BT-549 and Hs578T cells express high levels of TRPC4 and TRPC1/4, respectively, and are exquisitely, 2000- and 430-fold, more sensitive to englerin A than other TNBC cell lines. While englerin A caused a slow Na+ and nominal Ca2+ accumulation in Hs578T cells, it elicited rapid increases in cytosolic Ca2+ levels that triggered mitochondrial depolarization in BT-549 cells. Interestingly, BT-549 and Hs578T cells were also more sensitive to digoxin as compared to other TNBC cell lines. Collectively, these data reveal TRPC1/4 channels as potential biomarkers of TNBC cell lines with dysfunctional mechanisms of cation homeostasis and therefore sensitivity to cardiac glycosides. Conclusions: The sensitivity of BT-549 and Hs578T cells to englerin A and digoxin suggests a subset of TNBCs are highly susceptible to cation disruption and encourages investigation of TRPC1 and TRPC4 as potential new biomarkers of sensitivity to cardiac glycosides.",
keywords = "Cation disruption, Digoxin, Englerin A, Triple-negative breast cancer, TRPC1/4/5",
author = "Grant, {Corena V.} and Carver, {Chase M.} and Hastings, {Shayne D.} and Karthik Ramachandran and Madesh Muniswamy and Risinger, {April L} and Beutler, {John A.} and Mooberry, {Susan L}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10549-019-05324-7",
language = "English (US)",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",

}

TY - JOUR

T1 - Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype

AU - Grant, Corena V.

AU - Carver, Chase M.

AU - Hastings, Shayne D.

AU - Ramachandran, Karthik

AU - Muniswamy, Madesh

AU - Risinger, April L

AU - Beutler, John A.

AU - Mooberry, Susan L

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: Triple-negative breast cancers (TNBCs) represent a heterogeneous group of tumors. The lack of targeted therapies combined with the inherently aggressive nature of TNBCs results in a higher relapse rate and poorer overall survival. We evaluated the heterogeneity of TNBC cell lines for TRPC channel expression and sensitivity to cation-disrupting drugs. Methods: The TRPC1/4/5 agonist englerin A was used to identify a group of TNBC cell lines sensitive to TRPC1/4/5 activation and intracellular cation disruption. Quantitative RT-PCR, the sulforhodamine B assay, pharmacological inhibition, and siRNA-mediated knockdown approaches were employed. Epifluorescence imaging was performed to measure intracellular Ca2+ and Na+ levels. Mitochondrial membrane potential changes were monitored by confocal imaging. Results: BT-549 and Hs578T cells express high levels of TRPC4 and TRPC1/4, respectively, and are exquisitely, 2000- and 430-fold, more sensitive to englerin A than other TNBC cell lines. While englerin A caused a slow Na+ and nominal Ca2+ accumulation in Hs578T cells, it elicited rapid increases in cytosolic Ca2+ levels that triggered mitochondrial depolarization in BT-549 cells. Interestingly, BT-549 and Hs578T cells were also more sensitive to digoxin as compared to other TNBC cell lines. Collectively, these data reveal TRPC1/4 channels as potential biomarkers of TNBC cell lines with dysfunctional mechanisms of cation homeostasis and therefore sensitivity to cardiac glycosides. Conclusions: The sensitivity of BT-549 and Hs578T cells to englerin A and digoxin suggests a subset of TNBCs are highly susceptible to cation disruption and encourages investigation of TRPC1 and TRPC4 as potential new biomarkers of sensitivity to cardiac glycosides.

AB - Purpose: Triple-negative breast cancers (TNBCs) represent a heterogeneous group of tumors. The lack of targeted therapies combined with the inherently aggressive nature of TNBCs results in a higher relapse rate and poorer overall survival. We evaluated the heterogeneity of TNBC cell lines for TRPC channel expression and sensitivity to cation-disrupting drugs. Methods: The TRPC1/4/5 agonist englerin A was used to identify a group of TNBC cell lines sensitive to TRPC1/4/5 activation and intracellular cation disruption. Quantitative RT-PCR, the sulforhodamine B assay, pharmacological inhibition, and siRNA-mediated knockdown approaches were employed. Epifluorescence imaging was performed to measure intracellular Ca2+ and Na+ levels. Mitochondrial membrane potential changes were monitored by confocal imaging. Results: BT-549 and Hs578T cells express high levels of TRPC4 and TRPC1/4, respectively, and are exquisitely, 2000- and 430-fold, more sensitive to englerin A than other TNBC cell lines. While englerin A caused a slow Na+ and nominal Ca2+ accumulation in Hs578T cells, it elicited rapid increases in cytosolic Ca2+ levels that triggered mitochondrial depolarization in BT-549 cells. Interestingly, BT-549 and Hs578T cells were also more sensitive to digoxin as compared to other TNBC cell lines. Collectively, these data reveal TRPC1/4 channels as potential biomarkers of TNBC cell lines with dysfunctional mechanisms of cation homeostasis and therefore sensitivity to cardiac glycosides. Conclusions: The sensitivity of BT-549 and Hs578T cells to englerin A and digoxin suggests a subset of TNBCs are highly susceptible to cation disruption and encourages investigation of TRPC1 and TRPC4 as potential new biomarkers of sensitivity to cardiac glycosides.

KW - Cation disruption

KW - Digoxin

KW - Englerin A

KW - Triple-negative breast cancer

KW - TRPC1/4/5

UR - http://www.scopus.com/inward/record.url?scp=85068105712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068105712&partnerID=8YFLogxK

U2 - 10.1007/s10549-019-05324-7

DO - 10.1007/s10549-019-05324-7

M3 - Article

AN - SCOPUS:85068105712

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

ER -